• 45461 Citations
  • 114 Scopus h-Index
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jeff A Sloan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer

    Manzar, G. S., Lester, S. C., Routman, D. M., Harmsen, W. S., Petersen, M. M., Sloan, J. A., Mundy, D. W., Hunzeker, A. E., Amundson, A. C., Anderson, J. L., Patel, S. H., Garces, Y. I., Halyard, M. Y., McGee, L. A., Neben-Wittich, M. A., Ma, D. J., Frank, S. J., Whitaker, T. J. & Foote, R. L., Jun 2020, In : Radiotherapy and Oncology. 147, p. 64-74 11 p.

    Research output: Contribution to journalArticle

  • Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316)

    Deutsch, G. B., Deneve, J. L., Al-kasspooles, M. F., Nfonsam, V. N., Gunderson, C. C., Secord, A. A., Rodgers, P., Hendren, S., Silberfein, E. J., Grant, M., Sloan, J., Sun, V., Arnold, K. B., Anderson, G. L. & Krouse, R. S., Jan 1 2020, In : American Journal of Hospice and Palliative Medicine. 37, 1, p. 12-18 7 p.

    Research output: Contribution to journalArticle

  • Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)

    Chakravarthy, A. B., Zhao, F., Meropol, N. J., Flynn, P. J., Wagner, L. I., Sloan, J., Diasio, R. B., Mitchell, E. P., Catalano, P., Giantonio, B. J., Catalano, R. B., Haller, D. G., Awan, R. A., Mulcahy, M. F., O'Brien, T. E., Santala, R., Cripps, C., Weis, J. R., Atkins, J. N., Leichman, C. G. & 9 others, Petrelli, N. J., Sinicrope, F. A., Brierley, J. D., Tepper, J. E., O'Dwyer, P. J., Sigurdson, E. R., Hamilton, S. R., Cella, D. & Benson, A. B., May 1 2020, In : Oncologist. 25, 5, p. e798-e807

    Research output: Contribution to journalArticle

    Open Access
  • International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

    Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium, Feb 2020, In : The Lancet Oncology. 21, 2, p. e83-e96

    Research output: Contribution to journalReview article

  • 3 Scopus citations

    Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes

    Le-Rademacher, J. G., Lopez, C. L., Kanwar, R., Major-Elechi, B., Abyzov, A., Banck, M. S., Therneau, T. M., Sloan, J. A., Loprinzi, C. L. & Beutler, A. S., Apr 15 2020, In : Journal of the neurological sciences. 411, 116687.

    Research output: Contribution to journalArticle

    Open Access